Nivolumab/relatlimab versus nivolumab/ipilimumab for metastatic melanoma: A retrospective, propensity-matched cohort study.

Authors: Quaid Oza, Varada Salimath, Brittany Miles, James David Mackey

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21553

Source: Full article

---

Abstract

e21553